ADMA Biologics ADMA Plasma Collection Centers — Cost Of Revenue

Other segment segments

Similar metrics at other companies

HAEPlasma — Cost of goods sold

$54.39M+14.9%

HAEPlasma — Costs incurred, net of reversals

$0—

HAEPlasma — R&D

$4.94M+15.4%

HAEPlasma — Total net revenues

$130.29M+2.8%

HAEPlasma — Operating Income

$43.69M-13.7%

HAEBlood Center — Cost of goods sold

$30.67M+3.0%

Questions, answered.

What is ADMA Biologics's plasma collection centers — cost of revenue?

ADMA Biologics (ADMA) reported plasma collection centers — cost of revenue of $793K in Q1 2026.

How has ADMA Biologics's plasma collection centers — cost of revenue changed year-over-year?

ADMA Biologics's plasma collection centers — cost of revenue increased by 22.4% year-over-year, from $648K to $793K.

What is the long-term trend for ADMA Biologics's plasma collection centers — cost of revenue?

Over 3 years (2022 to 2025), ADMA Biologics's plasma collection centers — cost of revenue has grown at a 20.9% compound annual growth rate (CAGR), from $9.93M to $17.55M.

What does plasma collection centers — cost of revenue mean?

Includes the direct costs associated with operating plasma collection centers, such as donor compensation, center staffing, and supplies. This metric is critical for assessing the direct production efficiency of the plasma supply chain. Monitoring this helps determine the segment's ability to manage variable costs relative to plasma volume.